Mice previously latently infected with the F strain of herpes simplex virus type 1 (HSV-1) can be successfully colonized with a second virus strain if HSV-2 is introduced at the same peripheral site as HSV-1. On the other hand, HSV-1 strains seemed able mutually to exclude establishment of latency with each other. Mice (3 months or 3 years after nasal infection) latently infected with HSV-1 were thus superinfected with HSV-2. The mice were sacrificed 2 days post-infection when HSV-2 replication in the ganglia was found to have commenced. Ganglia were homogenized immediately and virus was plaqued on permissive cells. HSV-1 plaques were regularly obtained among HSV-2 plaques as assessed by staining with an enzyme-linked immunosorbent using a type-specific monoclonal antibody recognizing glycoprotein C of HSV-1. DNA from this virus had identical restriction endonuclease patterns (EcoRI, BamHI and HindlII) to the F strain used to infect the animals latently. HSV-1 was not retrieved from ganglia of controls superinfected with a neuroadapted vaccinia virus or were mocksuperinfected. The results suggest that it is possible to superinfect a latently infected ganglionic neuronal cell with a heterotypic HSV strain and that the subsequently introduced HSV-2 can act in trans to induce reactivation of latent HSV-1.
INTRODUCTION
Herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) can both establish latent infections in the nervous system (Plummer et al., 1970; Plummer, 1973) , the target cells being the sensory neurons (Stevens & Cook, 1971 ; Stevens et al., 1972) . The present method for detection of latent virus genomes in ganglia is so-called co-cultivation of minced ganglionic tissue and permissive cells (Stevens et al., 1972; Knotts et al., 1973) . This method has been modified (Wohlenberg et al., 1979; Harbour et al., 1981) , and instead of co-cultivation, whole ganglia are cultured before homogenization and seeding of homogenized ganglion cells onto permissive cells. How the activation of the latent HSV genome is accomplished is unknown but possibly a host cell-regulated suppression of viral replication ceases to operate as a result of the cultivation.
Evidence for the presence of cellular factors of importance for restriction of HSV infection in an in vitro system with C1300 neuroblastoma cells has been obtained (Vahlne et al., 1981; Nilheden et al., 1985a, b) . In C1300 cells, HSV replication is suppressed if the virus dose inoculated is low. When the amount of infective virus per cell is increased, the threshold of inhibition seems to be overcome and a productive infection is obtained (Vahlne et al., 1981) . We assume that a similar situation might exist for latency in vivo. If this is the case, then one could predict that virus replication would ensue when a sufficient critical number of viral genomes was introduced into the ganglionic neuronal cells. Experimentally, this might be obtained by e.g. superinfecting latently infected animals, using the same peripheral site for virus inoculation as that of the primary infection. However, it may be argued that a successful superinfection of latently infected ganglionic cells should not normally occur since previous studies have indicated that the first virus inoculated, colonizing the ganglion, would prevent a subsequently added virus strain from entering it (Price eta[., 1975; McKendall, 1977; Centifanto-Fitzgerald et al., 1982) . The existence of such an impediment to superinfection is also supported by findings that each attempt to recover virus from explanted, latently infected human ganglia has yielded a single virus strain only (Lonsdale et at., 1979) . On the other hand, Meigner et al. (1983) recently reported colonization of mouse ganglia with several, subsequentiaUy inoculated HSV strains. Brown eta/. (1979) and Lewis et aL (1984) have reported that superinfection in vitro with a temperature-sensitive mutant of explanted human ganglia that failed to release HSV spontaneously resulted in retrieval of HSV identical to the wild-type virus spontaneously released from other explanted ganglia of the same individual. However, it is not certain that the sensory neurons of human cadaver ganglia are still viable after extended cultivation in vitro.
In the present paper we address the question of whether, in superinfection of latently infected mice with a heterotypic HSV strain in viuo, the virus may act in trans and induce replication of a latently residing HSV genome. Such an induction would agree with the assumption that the mechanisms for establishment and maintenance of latency are under the influence of a host cellregulated suppression of virus replication.
METHODS

Viruses.
The HSV-1 strains F (B. Roizman, University of Chicago, Chicago, II1., U.S.A.) and K J502 (Vahlne et al., 1975) , a phosphonoformic acid (PFA)-resistant mutant PFAR of HSV-1, and the HSV-2 strain B4327UR (Jeansson, 1972) were used. All strains were propagated in green monkey kidney (GMK AH-1) cells. Suspensions of virus used contained 1 x 107 p.f.u./ml. A neuroadapted vaccinia virus strain (IHD) used, also propagated in GMK cells, is referred to as neurovaccinia virus.
The HSV strains were easily distinguishable by their marked strain-specific biological properties. Thus, B4327U R was identified by its HSV-2-specific immune characteristics, PFAR by its resistance to PFA and K J502 as a producer of large syncytial plaques. However, when required, the strain identity was confirmed by analysis after restriction endonuclease cleavage of HSV DNA.
Cells. GMK AH-I cells (Gfinalp, 1965) were grown, as previously described , in 50 mm plastic Petri dishes and were used for plaquing of virus.
Plaque titration o] HSV. For plaquing HSV, Eagle's MEM containing 1 ~ methyl cellulose was used. The cultures were incubated at 37 °C and plaques were counted on day 5 after virus inoculation (Kristensson et al., 1978) .
Type-specific staining of HSV-1 plaques. An enzyme-linked immunosorbent assay using the HSV-l-specific monoclonal antibody B1CI reacting with glycoprotein C (gC) of HSV-1 was used for staining of HSV-1 plaques (Nilheden et al., 1983) . Cells were not fixed, and to avoid background staining, 5~o calf serum was used in place of Tween-80 in all solutions throughout the staining procedure. The B1C1 antibody was used at a dilution of 1/100 (N ilheden et aL, 1983) . HSV-l plaques were readily distinguished from HSV-2 plaques and could be isolated, virus purified, and DNA analysed by restriction enzyme digestion. Neurovaccinia plaques were distinguished from HSV plaques by haemadsorption after incubation for 30 min with a 0.5~ suspension of chicken erythrocytes.
Plaque purification. Stained plaques were collected with a sterile Pasteur pipette and transferred to GMK cells. When a cytopathic effect was observed, another plaque titration and plaque staining procedure was performed. This procedure was repeated until a homogeneous population of stained plaques was achieved.
Purification and restriction endonuclease cleavage ofHS V DATA. Ten bottles of G MK cells (approx. 1 x 108 cells) were infected with 0.1 p.f.u, of HSV per cell in 10 ml of medium at 37 °C for 1 h. Eagle's MEM (20 ml) was then added to each bottle, which was incubated at 37 °C for 48 h. The infected cells were scraped off with a rubber policeman, washed twice in phosphate-buffered saline (PBS), and then collected by low-speed centrifugation (800 g for 10 min at 4 °C). HSV DNA was extracted by a modification of methods described previously (Green et al., 1971 ; Buchman et aL, 1978 ; Lonsdale et al., 1979 ; Pignani et al., 1979) . Five ml of lysing solution (0.25 ~ Triton X-100, 10 mM-EDTA, 10 mM-Tris HC1 pH 7.9) was added to the infected cells. After three strokes with a tight-fitting Dounce homogenizer, the sample was incubated at room temperature for 10 min with gentle mixing. NaC1 was then added to a final concentration of 0.2 M. Nuclei were pelleted by centrifugation at 4 °C, 2000 g for 10 rain. The supernatant was decanted and SDS and proteinase K (Merck, Kebo) were added to final concentrations of 0.6~ and 100 gg/ml, respectively. After incubation for 2 h at 37 °C, proteins were extracted twice with phenol and the remaining lipids were extracted with a mixture of chloroform and 2~ isoamyl alcohol. The deproteinized material, containing the virus DNA, was then dialysed for 36 h against several changes of Tris-EDTA buffer (10 mM-Tris HC1, 1 mM-EDTA, pH 7-4). NaCI was added to a final concentration of 0-2 M and the DNA was precipitated by 3 vol. ice-cold 96~ ethanol and centrifuged at 10000g, at 4 °C for 30 min. The pellet was washed twice with 70% ethanol, dried under vacuum, and dissolved in 200 Ixl Tris-EDTA buffer. Viral DNA was then IP: 54.70.40.11
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In vivo activation of latent HSV-I with HSV-2 1765 digested as described by Buchman et al. (1978) . Restriction endonucleases BamHI, HindIII and EcoRI were purchased from Boehringer, and for cleavage the appropriate buffer recommended by the supplier was used for each enzyme. Five ~tg DNA was cleaved at 37 °C with 5 units of enzyme. Digestion was stopped by the addition of 1/10 vol. of RE-stop (10 ~ Ficoll, 100 mM-EDTA, bromophenol blue dye). Restriction endonuclease fragments of HSV DNA were separated by horizontal agarose gel electrophoresis on 0.5% agarose gels for EeoRI digests and 0.8~ agarose gels for HindllI and BamH! digests (electrophoresis buffer: 35 mM-Tris, 30 mM-NaHzPO4, 1 mM-EDTA). The gels were stained with ethidium bromide (0.5 ~tg/ml) and photographed by transillumination using Polaroid film.
Mice and inoculation technique. Five-to 6-week-old Swiss albino mice of our own laboratory breed were used. Latent infection in trigeminal ganglia was established by scarification of the nose (Kristensson et al., 1979) . A drop of virus suspension was placed on both sides of the nose and virus was inoculated by scarification with a fine needle. This technique was also used in studies of acute infection and when latentIy infected mice were superinfected.
Preparation O[ trigeminal ganglionic tissue and brainstem. Ether-anaesthetized mice were perfused with PBS through the left cardiac ventricle and the brains were removed for exposure of the trigeminal ganglia and brainstem. Both trigeminal ganglia were removed and pooled; the brainstem was likewise removed. The tissue to be examined was placed in 1 ml PBS containing 200 units penicillin and 200 ~tg streptomycin per ml. It was minced with a glass rod and subsequently 2 ml Eagle's MEM was added and samples were homogenized by 30 strokes with a tight-fitting Dounce homogenizer. Cell debris was pelleted at 2000g for 10 min, supernatants were collected and titrated in GMK cells. Preculturing (Wohlenberg et al., 1979; Harbour et al., 1981) of latently infected ganglia in Eagle's MEM at 37 °C for 4 days before mincing and homogenization was done in some experiments, as indicated in Results.
RESULTS
Colonization of ganglia with more than one HSV strain
After infection by the nose with 106 p.f.u, of HSV-1 strain F, 75 to 100~ of the exposed mice developed latent infection in the trigeminal ganglia as assessed by virus isolation from the homogenized tissue of ganglia that had been precultured for 4 days (not shown). The presence of latent virus in ganglionic tissues was demonstrated up to at least 3 years post-infection. In the first experiment we tested whether our model permitted previously latently infected ganglia to be superinfected and whether latency with the superinfecting HSV strain could be established. Three HSV strains (PFAR, B4327UR and K J502) easily identifiable and distinguishable were serially inoculated into the nose of mice latently infected with the F strain according to the protocol indicated in Table 1 . Intervals of 14 days were allowed for latency to be established after each inoculation. Three weeks after infection with the last HSV strain administered, the mice were sacrificed. Each group of mice was divided into two. Ganglia collected from one of the subgroups were directly homogenized while those from the other subgroup were precultivated for 4 days before homogenization and seeding onto GMK cell monolayers. Left and right ganglia from the same animal were tested together. The virus isolated was plaqued in the presence and absence of PFA to distinguish F (syn +) progeny from that of PFAR. Large syncytial plaques were scored as KJ502, and 'white' plaques after immunoperoxidase staining using the HSV-l-specific monoclonal antibody were scored as B4327UR. In a second series of experiments the order of the strains inoculated was changed. The results are presented in Table  1 .
Virus was only isolated from ganglia that had been precultured for 4 days prior to homogenization. Latent virus with characteristics other than those of the virus first introduced into the ganglia was obtained in mice primarily infected with the F strain and superinfected with the B4327UR strain of HSV-2. Dual latent infections (F and B4327UR) were found in 30 to 50 of virus-positive ganglia. Plaques with K J502 characteristics were not obtained from ganglia of any mice latently infected with the F strain, although the K J502 virus itself was able to establish a latent infection (Table 1) , and replicates as well as the F strain in ganglia after peripheral inoculation (unpublished observations). Likewise HSV strain F appeared not to be able to colonize ganglia previously latently infected with K J502. Thus, the F and K J502 strains seemed able to exclude establishment of latency by each other. Also, the PFAR mutant of HSV-1 prevented the homotypic F strain from colonizing the ganglia, despite the apparent inability of this mutant to establish a reactivable latent infection. * Mice were infected percutaneously in the nose with 10 ~ p.Eu. of each HSV strain in the order indicated. Subsequent inoculations were performed 14 days after previous inoculation. 0, Mock inoculation.
t All mice were killed 3 weeks after the last nose inoculation. Left and right ganglia from each animal were pooled and precultured for 4 days before homogenization and plaquing. Strain discrimination was performed as stated in the text.
Since it was found that it was possible to introduce the HSV-2 strain B4327UR into ganglia of mice previously latently infected with the F strain of type 1, this combination of virus strains was chosen for further studies.
Course of acute infection in ganglia after peripheral infection
Fifty mice were infected in the nose with HSV-1 or HSV-2. To enhance HSV replication in the ganglia, the mice were given cyclophosphamide (CPA) at 200 mg/kg body weight intraperitoneally, 1 day prior to infection (Kristensson et al., 1982) . Five mice of each group were sacrificed each day after infection and ganglia were collected, homogenized and assayed for infectious virus. Brainstems were collected and tested in parallel to ensure that virus titres obtained from the ganglia were not influenced by contaminating virus replicating in the central nervous system (CNS). The results are presented in Table 2 .
The HSV-2 strain appeared more pathogenic than the HSV-1 strain. Thus, the HSV-2infected mice were all dead at 7 days, whereas all animals survived infection with HSV-1. Infectious virus appeared in the ganglia at 4 days after HSV-1 infection and titres peaked at 5 days. From day 7 and onwards, no replicating virus was detected in the ganglia of HSV-1infected mice. HSV-2, on the other hand, was detected in the ganglia even at 2 days, and titres were obtained which were more than 10-fold higher than those from HSV-l-infected mice. In both groups of animals, HSV replicated in the brainstem with a delay of about 1 day vis-~,-vis the pattern seen in the ganglia.
Invariably non-linear relationships were obtained between the amounts of HSV-1 used for infection and virus titres found in ganglia assayed at 5 days post-infection, i.e. at the peak of virus replication. As demonstrated in Table 3 , a fivefold reduction of inoculated virus resulted in an almost 20-fold decrease in the amount of virus detected in the ganglia (1150 p.f.u, compared to 64 p.f.u.) . After yet another fivefold reduction of the virus inoculum, no HSV replication was detected in the ganglia.
Retrieval of latent HSV-1 following superinfection with HSV-2
CPA (200 mg/kg body weight) was administered intraperitoneaUy to mice latently infected with HSV-1 (strain F; 106 p.f.u.) 3 months or more before. The following day the mice were superinfected with HSV-2 (strain B4327UR; 104 to 10' p.f.u.). Two days after superinfection the HSV-t and HSV-2 replication in mouse trigeminal ganglia and brainstems after snout * Groups of five mice were percutaneously inoculated in the snout with 106 p.f.u, of HSV-1 (strain F) or HSV-2 (strain B4327UR). CPA was given I day before infection. Tissues of the animals were pooled, homogenized and cell debris was removed by low-speed centrifugation before assay for virus.
t No determination available. :~ Two of five mice died and are not included in this figure. § All mice died. 1/25 0 0 * Mice were given CPA 1 day before infection with HSV. Tissues collected for virus titrations were immediately homogenized.
I Undiluted = 2 x 106 p.f.u. :~ P.f.u. recovered from pooled ganglia or brainstems of five animals. Fig. 1 . Comparison of the restriction endonuclease digestion patterns of retrieved and plaque-purified HSV-1 (R) after superinfection of HSV-1 latently infected mice with HSV-2 and that of the HSV-1 strain (F) used for establishing the Latent infection.
animals were sacrificed. The ganglia were removed, immediately homogenized and assayed for infectious virus by plaquing on G M K cells. Plaques obtained were tested for HSV-1 genetic information by immunoperoxidase staining using the B1C1 monoclonal antibody. Control animals were either mock-superinfected with Eagle's M E M in the nose or were superinfected with 106 p.f.u, of neurovaccinia virus. The latter virus replicated well at the site of inoculation, giving a pronounced crusting in the snout. Results of four separate experiments are presented in Table 4 . Infectious HSV-1 was regularly rescued from latently infected trigeminal ganglia of mice superinfected with l0 b p.f.u, of HSV-2, and the rescue was successful both in animals latently infected for 3 months and in mice latently infected for 3 years. In fact, slightly higher p.f.u, titres were obtained with the older animals. In no instance did mock superinfection or neurovaccinia virus superinfection induce reactivation of latent HSV-1.
Digestion of D N A from retrieved virus with three endonucleases (EcoRI, HindIII and BamHI) gave cleavage patterns identical to that of D N A from the HSV-1 F strain used to infect the animals latently (Fig. 1) .
In vivo activation of latent HSV-I with HSV-2 1769 DISCUSSION We have questioned in this paper whether a superinfecting heterotypic HSV could act in trans and thereby help the latently residing HSV-1 genome to overcome a presumed host cellregulated suppression. To do so, superinfeeting virus would have to infect an already latently infected neuron. There is as yet no direct proof of multiply infected ganglionic neurons in vivo, but some observations made by us and others might be circumstantial evidence that this might be the case. We have confirmed the results of Meigner et at. (1983) that a mouse trigeminal ganglion can be colonized with more than one HSV strain. In a preliminary report, Lewis et al. (1983) presented detection of multiple strains of latent HSV-1 in trigeminal ganglia of human cadavers. Their data suggest that multiple latent strains probably arise as a result of superinfection or simultaneous infection with more than one strain of HSV. The non-linear relationship found between inoculation dose and recovery of HSV progeny from ganglia during the acute phase of the infection (Table 3 ) might in fact be due to a neuronal regulated suppression of HSV in vivo and might be similar to the non-linearity of the HSV yield-inoculum relationship obtained with cultured mouse neuroblastoma cells (Vahlne et al., 1981) . Lastly, superinfection with HSV-2 in the nose of mice latently infected with HSV-1 did result in activation of HSV-1 replication, as revealed by the antigenic characteristics of progeny virus and the identical restriction endonuclease cleavage patterns of progeny virus DNA and DNA of the HSV-1 strain used for establishing the latent infection. In order to exclude the possibility that non-specific factors, such as nose-scraping or virus replication per se affected the retrieval of latent genomes, latently infected controls were superinfected with neurovaccinia virus. This virus replicated well at the peripheral site of inoculation, and infectious neurovaccinia virus was also found in the trigeminal ganglia. The route by which this virus reached the ganglia cannot be determined from the present study. However, since HSV-1 information was not retrieved from these control animals, we assume that the input of the related virus was required to reactivate the latent HSV-1 genome.
Immunological reactions are almost certainly involved in clearance of virus and termination of the primary infection in the peripheral tissue (Price et al., 1975; Wildy et al., 1982 ). An immunological response may locally suppress the replication of inoculated virus and restrict the superinfecting virus by reducing the infectious superinfecting virus dose transported to the ganglion. Such an immunological response might be the reason why the HSV-1 PFAR mutant, although itself apparently unable to establish a reactivable latent infection, could prevent a second HSV-1 strain from colonizing the ganglia. In this way, the relative resistance of HSV latency to activation by superinfection might also be explained. Nevertheless, HSV-1 genetic information was retrieved from up to 50~ of the HSV-1 latently infected, HSV-2 superinfected mice. This finding is to be compared with a recovery of about 80~ for virus from ganglia of latently infected mice in the absence of superinfection after co-cultivation or precultivation of the ganglia. Since probably only a fraction of neurons become latently infected after primary infection, the probability that superinfecting virus would reach the latently infected neurons is low. Interestingly, there was no noticeable difference between percentages of successful rescues in mice latently infected for 3 months and in animals latently infected for 3 years. Thus, once latency is established, it seems unlikely that another reorganization of the dormant genome would occur.
